Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3039% below fair value
$2.42+0.13 (+5.68%)
Close on Nov 13, 2026Market cap $138.39MP/E –Yield –
Abeona Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Abeona Therapeutics's total assets was $171.92M at Sep 30, 2026. For fiscal 2025 it was $219.57M, up 101.6% from the year before. Over ten years it grew 10.6% a year on average. The highest annual figure on record is $223.38M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $219.57M | +101.6% |
| FY2024 | Dec 31, 2024 | $108.93M | +70.2% |
| FY2023 | Dec 31, 2023 | $64.00M | -0.3% |
| FY2022 | Dec 31, 2022 | $64.21M | -19.3% |
| FY2021 | Dec 31, 2021 | $79.59M | -47.4% |
| FY2020 | Dec 31, 2020 | $151.20M | -32.3% |
| FY2019 | Dec 31, 2019 | $223.38M | +28.1% |
| FY2018 | Dec 31, 2018 | $174.40M | -2.4% |
| FY2017 | Dec 31, 2017 | $178.77M | +61.0% |
| FY2016 | Dec 31, 2016 | $111.06M | +38.7% |
| FY2015 | Dec 31, 2015 | $80.06M | +382.8% |
| FY2014 | Dec 31, 2014 | $16.58M | +2605.1% |
| FY2013 | Dec 31, 2013 | $613.00K | -64.6% |
| FY2012 | Dec 31, 2012 | $1.73M | -54.3% |
| FY2011 | Dec 31, 2011 | $3.79M | -56.8% |
| FY2010 | Dec 31, 2010 | $8.77M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $171.92M | -25.6% |
| Q2 FY2026 | Jun 30, 2026 | $179.51M | -27.1% |
| Q1 FY2026 | Mar 31, 2026 | $198.49M | +99.8% |
| Q4 FY2025 | Dec 31, 2025 | $219.57M | +101.6% |
| Q3 FY2025 | Sep 30, 2025 | $231.10M | +91.6% |
| Q2 FY2025 | Jun 30, 2025 | $246.23M | +83.8% |
| Q1 FY2025 | Mar 31, 2025 | $99.36M | +32.8% |
| Q4 FY2024 | Dec 31, 2024 | $108.93M | +70.2% |
| Q3 FY2024 | Sep 30, 2024 | $120.59M | +82.5% |
| Q2 FY2024 | Jun 30, 2024 | $134.00M | +150.2% |
| Q1 FY2024 | Mar 31, 2024 | $74.83M | +40.3% |
| Q4 FY2023 | Dec 31, 2023 | $64.00M | -0.3% |
| Q3 FY2023 | Sep 30, 2023 | $66.09M | +70.5% |
| Q2 FY2023 | Jun 30, 2023 | $53.55M | +19.7% |
| Q1 FY2023 | Mar 31, 2023 | $53.35M | -3.3% |
| Q4 FY2022 | Dec 31, 2022 | $64.21M | -19.3% |
| Q3 FY2022 | Sep 30, 2022 | $38.76M | -67.4% |
| Q2 FY2022 | Jun 30, 2022 | $44.72M | -65.8% |
| Q1 FY2022 | Mar 31, 2022 | $55.17M | -61.0% |
| Q4 FY2021 | Dec 31, 2021 | $79.59M | -47.4% |
| Q3 FY2021 | Sep 30, 2021 | $119.02M | -25.3% |
| Q2 FY2021 | Jun 30, 2021 | $130.68M | -20.5% |
| Q1 FY2021 | Mar 31, 2021 | $141.43M | -19.2% |
| Q4 FY2020 | Dec 31, 2020 | $151.20M | -32.3% |
| Q3 FY2020 | Sep 30, 2020 | $159.37M | +11.6% |
| Q2 FY2020 | Jun 30, 2020 | $164.38M | +3.1% |
| Q1 FY2020 | Mar 31, 2020 | $175.00M | +5.3% |
| Q4 FY2019 | Dec 31, 2019 | $223.38M | +28.1% |
| Q3 FY2019 | Sep 30, 2019 | $142.77M | -11.1% |
| Q2 FY2019 | Jun 30, 2019 | $159.41M | -4.4% |
| Q1 FY2019 | Mar 31, 2019 | $166.14M | -5.4% |
| Q4 FY2018 | Dec 31, 2018 | $174.40M | -2.4% |
| Q3 FY2018 | Sep 30, 2018 | $160.58M | +67.7% |
| Q2 FY2018 | Jun 30, 2018 | $166.70M | +72.5% |
| Q1 FY2018 | Mar 31, 2018 | $175.65M | +66.8% |
| Q4 FY2017 | Dec 31, 2017 | $178.77M | +61.0% |
| Q3 FY2017 | Sep 30, 2017 | $95.73M | – |
| Q2 FY2017 | Jun 30, 2017 | $96.66M | – |
| Q1 FY2017 | Mar 31, 2017 | $105.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $111.06M | – |
See a number that looks wrong?